Skip to main content
Veterinary Medicines

Versifel FeLV, suspension for injection

Authorised
  • Feline leukemia virus, strain Kawakami-Theilen, glycoprotein gp70

Product identification

Medicine name:
Versifel FeLV, suspension for injection
Versifel FeLV
Active substance:
  • Feline leukemia virus, strain Kawakami-Theilen, glycoprotein gp70
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline leukemia virus, strain Kawakami-Theilen, glycoprotein gp70
    8.10
    log2 geometric mean titre
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AA01
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • (ID2): 1 Box with 25 Bottle (Glass) with 1 Dose (25 Dose)
  • (ID1): 1 Box with 10 Bottle (Glass) with 1 Dose (10 Dose)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium SA
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.11457.01.1
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0254/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Poland
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 11/04/2025

2612138-parde-20120808.pdf

German (PDF)
Published on: 11/04/2025
Download

2612138-parde-20120808.pdf

English (PDF)
Published on: 18/09/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."